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Edited by Peter Tontonoz and Laszlo NagyAbstract In this review, we present evidence from human and
animal studies to evaluate the hypothesis that sleep and circadian
rhythms have direct impacts on energy metabolism, and repre-
sent important mechanisms underlying the major health epidem-
ics of obesity and diabetes. The ﬁrst part of this review will focus
on studies that support the idea that sleep loss and obesity are
‘‘interacting epidemics.’’ The second part will discuss recent evi-
dence that the circadian clock system plays a fundamental role in
energy metabolism at both the behavioral and molecular levels.
These lines of research must be seen as in their infancy, but nev-
ertheless, have provided a conceptual and experimental frame-
work that potentially has great importance for understanding
metabolic health and disease.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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A major aspect of virtually all behavioral and physiological
processes is daily variation mediated by the circadian timing
system. Diurnal rhythms are generated by an internal biologi-
cal clock that is synchronized to the 24-h day by environmental
cues, primarily the light:dark cycle. When external timing sig-
nals are absent, the 24-h rhythms ‘‘free run’’ with a period
close to 24 h, and are called ‘‘circadian’’ (about a day)
rhythms. Many rhythms are overt and easy to recognize, such
as the sleep–wake cycle, locomotor activity, and feeding behav-
ior. The sleep–wake cycle is arguably the master output
rhythm of the circadian clock, because the regulation of most
behaviors and physiological activities depend on whether the
organism is asleep or awake. A wide-range of less-easily ob-
served rhythms occurs internally and includes the daily regula-
tion of body temperature, adrenal corticosterone and pituitary
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doi:10.1016/j.febslet.2007.06.079sympathetic activation, energy metabolism (e.g., lipolysis, glu-
coneogenesis, insulin sensitivity, basal metabolic rate), as well
as gene transcription. The evolution of a circadian system sug-
gests that the ability of an organism to coordinate itself with
the environment (external synchronization) and to maintain
temporal organization of endogenous processes (internal syn-
chronization) confers optimal health and survival potential.
As we begin to unravel the many links between sleep, circadian
rhythms, and metabolism, the survival beneﬁts of temporal
organization are beginning to emerge.
The ﬁrst mammalian circadian clock gene was discovered in
1997 by researchers at Northwestern University, and was given
the name Clock (Circadian locomotor output cycles kaput), to
represent the altered circadian phenotype in the Clock mutant
mouse [1,2]. Since that time, there have been major advances in
understanding the molecular basis of the circadian clock,
including the discovery of many other circadian clock genes
and the ongoing elucidation of transcriptional–translational
feedback loops through which these clock genes interact [3].
Two important studies in the Clock mutant mouse provided
evidence that circadian clock genes may be involved in more
than just keeping time. First, it was demonstrated that mice
homozygous for the Clock mutation (on a C57Bl/6J back-
ground) exhibit signiﬁcant increases in daily wake time
(+2 h), and a smaller amount of rapid eye movement (REM)
sleep rebound following sleep deprivation compared to litter-
mate controls [4]. The high-wake phenotype observed in
Clock/Clock mice entrained to a 12L:12D cycle persisted when
they were free-running in constant darkness. Therefore, the
regulatory eﬀect of the Clock gene on sleep extends beyond
temporal consolidation and includes a component of sleep
homeostasis, the amount of daily sleep time and the compen-
satory response to sleep deprivation. More recently, we discov-
ered that Clock/Clock mice on a C57Bl/6J background develop
alterations in energy metabolism, including greatly attenuated
diurnal feeding and locomotor activity rhythms, hyperphagia,
and obesity with accompanying symptoms of the metabolic
syndrome: hyperleptinemia, hyperlipidemia, hepatic steatosis,
and hyperglycemia with insuﬃcient compensatory insulin pro-
duction, a hallmark of type 2 diabetes mellitus [5]. These
remarkable data indicate that the molecular circadian clock
has an important and direct role in maintaining energy homeo-
stasis in mice. It is possible that the eﬀects of clock genes on
multiple physiological systems are mediated through central,
as well as peripheral pathways. Recent landmark discoveriesblished by Elsevier B.V. All rights reserved.
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brain, but in many peripheral tissues important in energy
metabolism and cardiovascular function, including the heart,
liver, adipose tissue, and pancreas [6,7]. Thus, clock genes
are positioned to interact with or to represent a core compo-
nent of many diﬀerent molecular pathways, thereby, poten-
tially having many diﬀerent functional roles.
In this review, we will present evidence from human and ani-
mal studies to evaluate the hypothesis that sleep and circadian
rhythms have direct impacts on energy metabolism, and may
represent important mechanisms underlying the explosion of
obesity and the metabolic syndrome that has occurred in the
United States, that is now becoming recognized in many devel-
oping countries as well. The ﬁrst part of this review will focus
on evidence that has led to the idea that sleep loss and obesity
are ‘‘interacting epidemics.’’ The second part will discuss re-
cent evidence that the circadian system may play a fundamen-
tal role in energy metabolism at both the behavioral and
molecular levels. It should be noted that much of the provoc-
ative evidence that sleep and the circadian clock are involved in
energy metabolism has appeared only in recent years. There-
fore, this line of research must be seen as in its infancy, but
nevertheless, one that provides a framework for exciting future
research and discussion, and one with potentially great impor-
tance for understanding metabolic health and disease.1. Obesity and sleep loss: ‘‘interacting epidemics?’’
Two concurrent health trends have emerged over the past
few decades that are having a signiﬁcant eﬀect on society
and the health care system: (1) a continuous increase in the
incidence and severity of obesity and the metabolic syndrome,
and (2) a reduction in the average daily amount of sleep time
resulting in chronic sleep debt. Data from the Center for Dis-
ease Control and Prevention (National Health and Nutrition
Examination Surveys, www.cdc.gov) have shown that since
the 1980’s, the amount of overweight and obesity in the United
States has more than doubled in adults and nearly tripled in
children and adolescents, aﬀecting over 60% of the population
in some states [8]. Obesity is not limited to the United States
and is increasing around the world [9]. There are numerous
secondary complications resulting from obesity, particularly
symptomatology of the metabolic syndrome, including insulin
resistance, hyperglycemia, dyslipidemia, hypertension, inﬂam-
mation, and coagulation disorders. Obesity and the metabolic
syndrome have been linked to heart attack, stroke, diabetes,
cancer, obstructive sleep apnea, and arthritis, making them
responsible, at least in part, for some of the major health prob-
lems facing the industrialized world today.
Over the same time period that obesity has reached epidemic
levels, the amount of daily sleep time achieved by American
adults has decreased by 1–2 h and recent data show that ado-
lescents are even more severely sleep deprived than adults [10–
13]. As of 2006, there were at least 35 epidemiological studies
linking alterations in sleep time with adverse health outcomes,
including obesity, diabetes, metabolic syndrome, and cardio-
vascular disease [14]. The important question is whether these
parallel outcomes are indeed ‘‘interacting’’ or simply corre-
lated with no cause and eﬀect relationship. The following sec-
tions will overview evidence from clinical research and animal
studies that support a direct role of sleep loss as an underlyingcause or pre-disposing factor for alterations in energy homeo-
stasis and disease states, such as obesity and diabetes.1.1. Human laboratory studies
Van Cauter and colleagues were the ﬁrst to report, in well-
controlled, experimentally rigorous clinical studies, changes
in glucose regulation and appetite following just a few days
of partial sleep restriction. For example, healthy male subjects
restricted to a 4-h sleep opportunity each night for six consec-
utive nights exhibited elevated glucose levels and decreased
insulin sensitivity following ingestion of breakfast on the last
day of sleep restriction [15]. Sleep restricted subjects also had
a signiﬁcant decrease in the rate of glucose disposal and a
reduction in insulin secretion in response to an intravenous
glucose tolerance test. The extent to which glucose and insulin
responses were impaired is comparable to what occurs in aging
or in the early stages of diabetes, suggesting that even longer
periods of sleep restriction in healthy young adults may indeed
represent a risk factor for impaired glucose homeostasis and
diabetes. In a second study by Van Cauter and colleagues,
4 h of sleep restriction for only two consecutive nights resulted
in notably reduced circulating levels of the anorectic hormone,
leptin, and increased levels of the orexigenic hormone, ghrelin,
along with self-reports of increased appetite [16]. These ﬁnd-
ings are in line with epidemiological data from the Wisconsin
Sleep Cohort Study that included over 1000 subjects, which
showed reduced leptin and increased ghrelin levels in self-re-
ported short sleepers [17]. These clinical studies controlled
for daily caloric intake and activity levels, but it was estimated
that if the self-reported appetite ratings in sleep restricted sub-
jects were translated into actual caloric intake, it would repre-
sent an extra 350–500 k/cal per day, enough to result in excess
weight gain if the pattern were to be maintained on a chronic
basis.
Other physiological changes detected following experimental
sleep restriction include elevated sympathovagal balance,
hypercortisolemia, increased thyroid hormone turnover, ele-
vated C-reactive protein levels, and increased secretion of
pro-inﬂammatory cytokines [15,18,19]. An important question
to consider is whether the neuroendocrine and metabolic ef-
fects of sleep curtailment result directly from the sleep loss it-
self, or through changes in other physiological pathways
aﬀected by sleep loss, such as the sympathetic nervous system
or the hypothalamo-pitiutary-adrenal (HPA) axis; the speciﬁc
mechanisms underlying the eﬀects of sleep loss on energy
metabolism remain to be elucidated. The major impact of
the initial clinical studies is that they provide laboratory sup-
port for the epidemiological based links between sleep and en-
ergy metabolism. The experimental studies also show that
sleep loss can precede and lead to signiﬁcant alterations in en-
ergy homeostasis.1.2. Animal laboratory studies
In rodent studies, chronic total sleep deprivation paradigms
have been utilized to demonstrate eﬀects of sleep loss on energy
metabolism. A series of studies using the classic disk-over
water (DOW) technique of sleep deprivation in rodents re-
vealed that chronic total sleep deprivation over a 2-week per-
iod resulted in hyperphagia, increased energy expenditure
(i.e. weight loss), initial hyperthermia followed by hypother-
mia, elevated sympathetic tone (increased norepinephrine
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mone turnover [20]. Other important neuroendocrine changes
following sleep deprivation using the DOW included a de-
crease in the satiety hormone, leptin, as well as reduced serum
levels of insulin-like growth factor 1 (IGF-1), growth hormone,
and prolactin [21]. Interestingly, if sleep deprivation was
stopped, many of these symptoms were largely reversible fol-
lowing a period of sleep recovery, indicating that some prop-
erty inherent to the sleep state mediated these changes.
We have performed intraperitoneal glucose tolerance tests in
rats following 1 day of sleep restriction (20 h of sleep depriva-
tion followed by 4 h of sleep) by sleep depriving rats in a slowly
rotating wheel (unpublished data). These preliminary ﬁndings
show that sleep loss results in decreased insulin secretion and
impaired glucose disposal following a single injection of dex-
trose (2 g/kg i.p.). Interestingly, chemical sympathectomy
using 6-hydroxydopamine signiﬁcantly reduced, but did not
eliminate, the extent of insulin and glucose impairment follow-
ing sleep loss, indicating that sympathetic tone may be an
important mediator of sleep loss on insulin and glucose
homeostasis in rodents. We are currently examining whether
repeated sleep restriction can exacerbate the diabetic state in
Zucker Diabetic Fatty (ZDF) rats.
Other sleep deprivation methods in rats have been used to
show metabolic consequences of sleep deprivation of varying
durations. During a 20-day period of REM sleep loss, rats
developed hyperphagia, increased metabolic rate (i.e. elevated
uncoupling protein-1 expression in brown adipose tissue), and
decreased leptin levels accompanied by upregulated mRNA
expression of neuropeptide-Y (NPY), an orexigenic neuropep-
tide, and downregulated mRNA expression of pro-opiomela-
nocortin (POMC), an anorectic neuropeptide, in the
hypothalamus [22,23]. Even a short period of sleep deprivation
for 5 h by gentle handling increased feeding while decreasing
leptin and increasing ghrelin concentrations in rats [24].
In combination, these studies show that chronic total sleep
deprivation in rats and chronic partial sleep restriction in hu-
mans both result in notable changes in components of energy
metabolism that could predispose or directly result in altered
metabolic function. Many consequences of sleep loss are con-
sistent between human and animal studies including: (1) in-
creased food intake and appetite, (2) decreased leptin and
increased ghrelin levels, (3) activation of the sympathetic ner-
vous system, (4) elevation of corticosterone levels, (5) altera-
tions in glucose utilization and, (6) an increase in
cardiovascular risk factors. The major diﬀerence between hu-
man and animal studies is that short sleep time in humans is
associated with increased BMI, whereas chronic total sleep
deprivation in animals usually leads to decreased body weight,
or negative energy balance. One reason for this diﬀerence
could involve methodological issues. The majority of animal
studies have used prolonged total sleep deprivation, rather
than chronic partial sleep restriction to assess changes in food
intake, body weight or other measures of energy homeostasis.
Second, all current animal methods of sleep deprivation in-
volve some degree of forced locomotion or physical manipula-
tion of the animals to keep them awake, whereas human
studies have controlled for activity by keeping subjects under
bed rest conditions. Third, human studies of chronic partial
sleep restriction have controlled nutrient intake by giving con-
trol and experimental subjects meals with identical caloric in-
take or by using constant glucose infusion, therefore, theseexperiments do not assess ad lib food intake and body weight
changes as has been the case in animal sleep deprivation stud-
ies. Another factor that could lead to diﬀerences in the body
weight response of humans and rodents could involve physio-
logical diﬀerences. In rodents, brown adipose tissue (BAT)
contributes to heat loss through non-shivering thermogenesis
and could substantially contribute to negative energy balance
following sleep deprivation, particularly in response to in-
creased sympathetic tone; BAT is not present in adult humans.
In summary, except for the eﬀects on body weight, the
majority of neuroendocrine changes following sleep loss are
similar between humans and animals, indicating that such ani-
mal models will continue to be valuable in determining the
mechanistic links and common physiological and molecular
components between sleep regulatory and energy metabolism
regulating systems.1.3. Eﬀects of altered metabolism on sleep–wake patterns
While it is clear that sleep is important in maintaining energy
balance, there are a variety of examples of how metabolic
pathways reciprocally interact to inﬂuence sleep–wake regula-
tion. A major ﬁnding that set the stage for investigating neural
interconnections linking sleep and metabolic homeostasis was
the discovery that the appetite regulating neuropeptides, hyp-
ocretin-1 (Hcrt-1) and hypocretin-2 (Hcrt-2) (also termed orex-
in-1 and orexin-2) are involved in sleep–wake regulation [25].
The hcrt system has an important wake-promoting function
and is involved in the control of motor activity. A defect in
the hcrt-2 receptor, as well as destruction of hcrt-containing
neurons in the hypothalamus, have been determined as causa-
tive factors in the canine and human forms of the sleep disor-
der, narcolepsy [26]. Interestingly, survey investigations have
reported that BMI may be elevated in narcoleptic patients
[27], and animal studies indicate that feeding and energy
expenditure problems in hcrt deﬁcient mice are directly related
to the disruption in sleep–wake patterns [28]. Therefore, hcrt
represents an important example of a molecule involved in
the co-regulation of sleep and energy metabolism, as it may
play a role in coordinating periods of sleep, food consumption
and energy storage.
Other metabolic hormones and perturbations inﬂuence
sleep–wake patterns. Diet induced obesity in mice leads to an
increase in non-rapid eye movement (NREM) sleep time and
increased sleep fragmentation, whereas in rats, food depriva-
tion results in decreased sleep time [29,30]. Appetite regulating
hormones and neuropeptides, such as insulin, ghrelin, and neu-
ropeptide Y (NPY) exert eﬀects on sleep time when adminis-
tered centrally or peripherally [31]. Acute administration of
the adiposity-signalling hormone, leptin, decreases REM sleep
and increases NREM sleep time in rats [32]. Furthermore, sub-
stances such as histamine and serotonin have important roles
in the control of both feeding and sleep–wake patterns [31].
We have recently shown that leptin deﬁcient, ob/ob, mice exhi-
bit high amounts of sleep time, a severely fragmented sleep–
wake pattern, and a disrupted circadian distribution of REM
sleep time and NREM EEG delta power, a quantitative mea-
sure of sleep homeostasis [33]. We have similar ﬁndings in
sleep–wake patterns in db/db mice and ZDF rats, which pro-
duce leptin, but harbor a mutation in the leptin receptor
(unpublished observations). Cytokines, such as tumor necrosis
factor-alpha (TNF-a) and interleukin-1 (IL-1), are produced in
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obesity, and have notable eﬀects on sleep [31]. Thus, many
of the primary neuropeptides and neurotransmitters involved
in the regulation of energy homeostasis also mediate sleep–
wake states, providing further evidence for overlap at the
mechanistic level between sleep and metabolic regulatory sys-
tems. A common thread in animal models of obesity (whether
genetic or diet induced) is that total sleep time is increased,
however, sleep is less consolidated as evidenced by frequent
arousals from sleep and increased sleep during the normal
wake period (i.e. during the dark phase for nocturnal rodents).
1.4. A novel model of chronic partial sleep loss: allostasis
One of the major factors governing sleep–wake regulation is
sleep homeostasis. Following short-term sleep deprivation, hu-
mans and animals compensate by increasing sleep intensity, as
deﬁned by NREM EEG delta (1–4 Hz) power, and usually
NREM and REM sleep time. We have recently developed a
model of chronic partial sleep restriction in rats and have made
the novel discovery that following repeated days of sleep loss,
rats lose the ability to generate a homeostatic sleep response,
as depicted in Fig. 1 [34]. We propose that this pattern is indic-
ative of a change in the recovery strategy from homeostasis to
allostasis [35]. It is conceivable that sleep loss creates an allo-
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Fig. 1. Chronic partial sleep restriction in rats: change from homeostatic to a
A 24-h baseline (BL) sleep–wake recording was collected beginning 4 h after
animals were sleep deprived for 20 h (SD1–SD5) followed by a restricted
ad libitum sleep recovery (R1-R3) opportunity. The 12:12 light:dark cycle
bar = dark phase). (B) NREM delta power during the daily sleep opportuni
wave activity (i.e. NREM delta [1.0–4.0 Hz] power) in the EEG during NREM
was a robust increase in sleep intensity during the 4-h sleep opportunity (grey b
drive for sleep. Surprisingly, rats were not able to exhibit a homeostatic drive
delta power regressed to baseline levels). This lack of sleep homeostasis even p
of an EEG trace during NREM sleep (10 s) during normal sleep conditions (
depicts an increase in the degree of slow wave activity in response to acute s
greatly diminished when animals are repeatedly sleep restricted. We interpret
conditions of chronic partial sleep loss.of a variety of physiological processes, but that also feeds back
to aﬀect the sleep–wake regulatory process itself. In turn, the
allostatic load resulting from sleep loss could then feed into
other physiological systems to exert a wide range of eﬀects,
including adaptations in energy metabolism. The biological
model of allostasis may prove valuable in establishing a frame-
work around which to investigate and understand the many
physiological consequences of chronic partial sleep loss.2. Circadian rhythms and energy metabolism
The discovery of the molecular basis of the circadian clock
(i.e. circadian clock genes) and the development of animal
models (genetic and non-genetic) of circadian disruption have
played a crucial role in understanding how the circadian sys-
tem controls a wide-range of output rhythms, and has eluci-
dated other potentially important roles of the circadian
system that extend well beyond its role as a time keeper. One
of the most exciting recent discoveries is that circadian clock
genes exist throughout the brain, as well as in numerous
peripheral tissues throughout the body [3,6,7]. These discover-
ies have resulted in novel ways of thinking about how the cir-
cadian system is involved in regulating multiple physiological
and molecular processes, including those relating to energy50%
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is indicated at the bottom of the ﬁgure (open bar = light phase, dark
ties. Sleep intensity was quantiﬁed by determining the amount of slow
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for sleep on subsequent days of sleep restriction (i.e. SD2–SD5, NREM
ersisted throughout the full 3-day recovery period. (C) Representation
top) and following acute sleep deprivation (bottom). The bottom trace
leep loss. The ability to generate this amount of slow wave activity is
this pattern as a strategic change from homeostasis to allostasis during
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an underlying factor in many diseases, such as obesity and the
metabolic syndrome, and associated cardiovascular disease.
This section will provide an overview of the anatomical and
molecular components of the circadian clock system and will
discuss recent ﬁndings pointing to an important role of circa-
dian regulation and circadian clock genes in energy metabo-
lism.2.1. The circadian clock: external and internal synchronization
A primary role of the circadian clock is to entrain the organ-
ism to environmental cues, such as the light:dark cycle (exter-
nal synchronization). Entrainment allows the animal to predict
many ﬂuctuations in the environment, such as dusk and dawn,
food availability, predator risk, prey availability, and temper-
ature changes that require survival-dependent changes in
behavior. Another critical role of the circadian system is to
maintain internal synchronization between multiple behaviors,
physiological systems, and molecular pathways to insure that
each of these processes, ranging from the sleep–wake cycle,
to hormonal rhythms, to gene transcription, are properly
aligned. Diﬀerent rhythms exhibit peaks and troughs of activ-
ity at diﬀerent times of day, but an important aspect of circa-
dian regulation is that these rhythms are expressed in a
particular phase relationship to one another. For example,
the initial period of nocturnal sleep in humans is characterized
by slow wave sleep, elevated growth hormone (GH) levels and
increased blood glucose concentration. In combination, re-
duced glucose utilization by non-insulin dependent and insulin
dependent tissues during slow wave sleep and the ability of GH
to increase hepatic gluconeogenesis and reduce insulin release
from pancreatic beta cells, allows glucose levels to be main-
tained throughout the prolonged fasting state of sleep. On
the other hand, cortisol levels increase near the end of the sleep
period and contribute to enhanced cardiovascular tone and
glucose utilization, two physiological processes that contribute
to optimal waking behavior. While these represent only two
examples of internal synchronization related to sleep and
metabolism, there are many scenarios of temporal coordina-
tion between physiological systems that are involved in a wide
range of functions, including not only energy metabolism, but
also cognitive performance, immune function, autonomic ner-
vous system homeostasis, cell growth, and possibly drug treat-
ment eﬃcacy (i.e. chronopharmacology).
A common example of circadian desynchronization occurs
in shift-work, where an individual is forced to be awake, to
eat, and to perform physical and cognitive tasks at times of
day that may not be aligned with endogenous internal
rhythms. Indeed, shift work has been linked to increased
BMI and higher rates of gastrointestinal disorders, cardiovas-
cular disease, as well as diabetes [36]. Few animal models of
‘‘shift work’’ have been developed, but one provocative study
demonstrated that reversing the light:dark cycle on a weekly
basis hastened death in cardiomyopathic hamsters, suggesting
that circadian desynchronization may have exacerbated and
complicated the pre-disposed disease state in these animals
[37].
Body weight, diabetes, and cardiovascular disease increase
with age, and there is evidence of anatomical changes in circa-
dian pacemaker neurons in the brain, as well as changes in the
timing of circadian gene expression in the paraventricular nu-cleus (PVN), a region of the hypothalamus important for the
integration of metabolic signals, as well as output of the auto-
nomic nervous system [38]. Interestingly, Buijs and colleagues
have hypothesized that a predisposing factor for type 2 diabe-
tes may be an imbalance in the temporal regulation of sympa-
thetic and parasympathetic inputs to target endocrine organs,
such as the liver, adrenal gland and adipose tissue [39,40]. It is
well-known that adverse cardiovascular events, such as hyper-
tension, congestive hear failure, arrhythmias, and myocardial
infarction are more likely to occur at certain times of day
[41]. Until recently, the hypothesis that internal synchroniza-
tion may play an important role in physiology has been in-
ferred based on easily observable rhythms without direct
measurements of phase relationships between internal
rhythms. The possibility of internal desynchronization as an
underlying factor in disease states is particularly attractive in
view of the recent and accumulating evidence that many tissues
throughout the body contain the molecular circadian clock
gene machinery. It is conceivable that in situations such as
shift-work, travel across time zones, and even conditions of
sleep deprivation, individual oscillators can become desyn-
chronized from one other, whereas, under routine conditions,
these separate oscillators are entrained in an organized phase
relationship.2.2. The suprachiamatic nucleus: master circadian pacemaker
The suprachiasmatic nuclei (SCN) consist of two bilaterally
paired groups of neurons situated just above the optic chiasm
in the anterior hypothalamus [3,42]. This structure represents
the master circadian pacemaker in the brain and its activity
underlies the maintenance and coordination of most behav-
ioral and physiological rhythms (i.e., internal synchronization)
of the body. The pacemaker function of the SCN was initially
suggested in rodents with the demonstration that SCN lesions
eliminate a wide range of rhythms, including the sleep–wake
cycle, locomotor activity, corticosteroid and leptin levels, glu-
cose tolerance, as well as feeding and drinking behavior [42].
Neurons in the SCN also contain hormones and neurotrans-
mitters that are synthesized and released in a circadian man-
ner, including transforming growth factor-a (TGF-a),
prokineticin-2 (PK2), gamma-aminobutyric acid (GABA),
and vasopressin [7]. Both TGF-a and PK2 suppress locomotor
activity, raising the possibility that their endogenous pattern of
release in the hypothalamus contributes to the locomotor
activity rhythm. While it has remained unclear exactly how
SCN activity is translated into synchronized eﬀector signals
to drive and coordinate multiple behavioral and physiological
rhythms, progress has been made in identifying some of the
key anatomical pathways comprising the SCN input and out-
put system.2.3. Anatomical model of SCN out signaling
The SCN receives light input from the eye via the retinohy-
pothalamic tract (RHT), which originates in non-visual photo-
receptive retino-ganglion cells [7]. Interestingly, these cells are
distinct from rods and cones, and contain the photopigment,
melanopsin. In the absence of light:dark cues, the circadian
clock in the SCN ‘‘free-runs’’ with a period close to, but not
exactly, 24 h. Signal transduction through the RHT represents
the major pathway by which the SCN is entrained to precisely
match the environmental light:dark cycle.
Fig. 2. Schematic of SCN input and output pathways in the hypothalamus. Environmental light:dark cues are transduced to the suprachiasmatic
nuclei (SCN) via the retinohypothalamic tract (RHT). The SCN sends a major projection to the ventral and dorsal subparaventricular zone (vSPZ
and dSPZ), which then transmits SCN signals to a variety of nuclei involved in sleep–wake, feeding, energy expenditure, and autonomic regulation
(details provided in text). ARC, arcuate nucleus; DMH, dorsomedial nucleus of the hypothalamus; LHA, lateral hypothalamic area (including
hypocretin and melanin concentrating hormone – containing neurons); PVN, paraventricular nucleus; MPOA, medial preoptic area; VLPO,
ventrolateral preoptic area. Coronal sections of the anterior and posterior hypothalamic areas – note that the SCN, SPZ and ACR are located in the
mediobasal hypothalamus surrounding the third ventricle. (Adapted from Saper [43]).
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tracing and lesion studies to deﬁne the major hypothalamic
targets of SCN eﬀerent projections [43]. They have proposed
a model by which the major SCN projection leads to the ven-
tral and dorsal regions of the subparaventricular zone (SPZ) of
the hypothalamus (Fig. 2). The SPZ is a relay between the
SCN and the dorsomedial nucleus of the hypothalamus
(DMH), which, in turn, sends projections to areas such as:
(1) the ventrolateral preoptic area (VLPO), important in
sleep–wake control, (2) the paraventricular nucleus (PVN),
which contains neurons that synthesize corticotrophin releas-
ing hormone (CRH) and neurons that mediate pre-ganglionic
outputs of the autonomic nervous system, and (3) the lateral
hypothalamic area, where the hunger-stimulating neuropep-
tides, hypocretin and melanin-concentrating hormone, are
produced. Discrete neurotoxic lesions of the SPZ and DMH
impair sleep and metabolic rhythms, indicating that these nu-
clei are important anatomical sites where the SCN is integrated
with sleep and metabolic regulatory signals [44].
The DMH receives input from the arcuate nucleus, an area
of the mediobasal hypothalamus that has been well character-
ized with respect to the regulation of food intake and energy
expenditure, as well as for the ability to monitor peripheral en-
ergy status, particularly through leptin receptor signaling [43].
In nocturnal rodents, DMH activity, as measured by c-fos
expression, is highest during the dark phase, in conjunction
with the major period of wakefulness, activity, and food intake
[43]. If food availability is restricted to a speciﬁc block of time
during the light phase over multiple consecutive days, rhythms
in wakefulness, locomotor activity, body temperature, cortico-sterone release, and DMH c-fos expression shift to anticipate
(by a few hours) the next block of food availability [45,46].
This pattern of food entrainment still occurs in SCN-lesioned
animals, indicating that a separate food entrainable oscillator
(FEO) exists, independent of the SCN [47]. There has been
great interest in identifying the anatomical location of the
FEO, however, despite several investigations, it has remained
elusive. While a recent study provided convincing data that
the FEO may reside within the DMH [44], contradictory evi-
dence to this hypothesis has also been reported [48].
The ability of the organism to entrain to a cue, other than
the light:dark cycle, has broad implications for understanding
circadian organization. The existence of the FEO opens up the
possibility that peripheral oscillators may be controlled by a
range of factors, including particular behaviors, neuro-hor-
monal signals, or local peripheral processes. Therefore, not
only may circadian disruption predispose an animal or human
to alterations in metabolic function (e.g. obesity, diabetes, and
cardiovascular disease), it is conceivable that circadian clocks
are reciprocally modulated by inputs relaying information
about adiposity, glucose homeostasis, sympathetic and para-
sympathetic balance, or behavioral status (e.g. feeding, sleep
deprivation). For example, sleep deprivation has been shown
to shift the circadian clock, even when stress and overall activ-
ity levels have been controlled [49]. In murine models of obes-
ity and diabetes, it is common to ﬁnd attenuated rhythms of
food intake, locomotor activity, and body temperature [50–
53]. Intriguingly, when db/db mice, Zucker obese rats, and
H1 receptor deﬁcient mice are provided with food only during
the dark phase, their increase in weight gain is attenuated,
Fig. 3. Transcriptional–translational feedback loop of core circadian clock genes. This diagram depicts the positive (CLOCK:BMAL1) and negative
(PER:CRY) limbs of the circadian clock gene feedback loop that is present in virtually all cells throughout the body. REV-ERBa and RORa
represent components of a secondary feedback loop that either activate (solid line with arrow) or inhibit (dashed line) Bmal1 activity. The
CLOCK:BMAL1 transcription complex has the ability to directly mediate the activity of genes (clock controlled genes) critically involved in energy
metabolism, including Dbp and Ppara. In turn, PPARa can directly bind to Bmal1 and inﬂuence activation of the positive limb of the feedback loop.
BMAL1, brain muscle arnt like factor; CLOCK, circadian locmotor output cycles kaput; CRY, cryptochrome; DBP, albumin D-element binding
protein; PER, period; PPARa, peroxisome proliferator-activated factor alpha; REV-ERBa, reverse erythroblastosis virus alpha; RORa, retinoic acid
receptor-related orphan receptor alpha; RXRa, retinoid X receptor alpha. (Adapted from Kohsaka [6]).
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parameters show improvement [50–52]. The ability of a high
fat diet to induce weight gain is prevented when rats are fed
only during the primary eating phase, the dark period [54].
A novel study showed that in response to restricted feeding,
Zucker obese rats exhibited more robust food anticipatory
behavior compared to lean rats, indicating a stronger response
of the FEO [55]. Additionally, our laboratory has performed a
variety of studies that demonstrate caloric restriction and
experimental manipulations of glucose availability and metab-
olism alter the response of the circadian system to the phase
shifting and entraining eﬀects of light [56–58]. All of these
studies provide evidence for intersections between circadian
and metabolic control systems. An understanding of the fun-
damental basis for this interplay is beginning to emerge due
to advances in the ﬁeld of molecular biology and the discov-
ery/characterization of circadian clock genes.
2.4. The molecular basis of circadian rhythms: circadian clock
genes
The ability of the SCN to entrain to the L:D cycle and to
generate endogenous rhythms in the absence of environmental
cues is based on molecular events involving an integrated cir-
cuit of circadian clock genes that exists in individual neurons
of the SCN. This circuit, which is highly conserved across spe-cies, involves transcriptional–translational feedback loop(s)
of core circadian clock genes, and cycles naturally with a near
24-h periodicity [3]. In mammals, Clock and Bmal1 (also called
Mop3) encode the bHLH-PAS domain-containing transcrip-
tion factors, CLOCK and BMAL1, which dimerize to form
the positive (i.e. active) limb of the feedback loop (Fig. 3).
The CLOCK:BMAL1 complex drives transcription of the neg-
ative limb (i.e. repressor) genes, Period (Per1,Per2, and Per3)
and Cryptochrome (Cry1 and Cry2), by binding to E-box cis-
regulatory enhancer elements in their promoter region. In the
cytoplasm, PER and CRY proteins dimerize, translocation
to the nucleus, and inhibit further Per and Cry transcription
by suppressing activity of CLOCK:BMAL1, thus, completing
the negative loop. Post-translational events, such as the cyto-
plasmic phosphorylation of PER:CRY by casein kinase Ie
(CKIe), can slow the translocation of PER:CRY into the nu-
cleus and inﬂuence the timing of the molecular clock. In addi-
tion, CLOCK:BMAL1 activates transcription of the orphan
nuclear receptors, reverse erythroblastosis virus a (Rev-erba),
which inhibits Bmal1 expression, and retinoic acid receptor-re-
lated orphan receptor a (Rora), which activates Bmal1 expres-
sion, to form a secondary feedback loop. The signiﬁcance of
REV-ERBa and RORa as components of the clock machinery
for understanding how the circadian clock and energy regulat-
ing systems may be tied together at the molecular level is that
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ways related to energy metabolism [59], as we will discuss be-
low.2.5. Clock controlled genes and clock-metabolic gene interplay
The ability of non-SCN tissue to generate self-sustaining
oscillations in clock gene expression was ﬁrst clearly demon-
strated in cultures of the rat retina and rat-1 ﬁbroblast cells
[60]. Subsequently, the Per1 gene was shown to exhibit circa-
dian oscillations in liver explants using the bioluminescent re-
porter gene, luciferase [61]. Several core clock genes in the liver
can entrain to scheduled feeding (i.e. the FEO), independently
of clock gene rhythms in the SCN [45–47]. The activity of the
core circadian clock genes must somehow be translated into
downstream signals in order to aﬀect cellular processes and
to translate these cellular events into physiological and behav-
ioral responses. DNA microarray analysis has revealed that
around 5–10% of the transcriptome displays oscillations in
mRNA expression levels in the SCN, liver, heart, vasculature,
and adipose tissue [62–66]. There is little overlap in the genes
that cycle between diﬀerent tissues, indicating that the down-
stream targets of the core clock machinery are unique to par-
ticular tissues, which diversiﬁes the role of the circadian clock
in the regulation of individual tissue/organ systems. Further-
more, the same clock gene can exhibit diﬀerent expression pro-
ﬁles between tissues, indicating that its role may not be
identical throughout the body [67]. Many clock controlled
genes (CCGs) are components of cellular metabolic pathways
raising the possibility that metabolic and circadian gene net-
works may be co-regulated [6,68]. This also means that a dis-
rupted molecular circadian clock may underlie a wide-range
of disorders and disease processes, including obesity, diabetes,
and other components of the metabolic syndrome. Recent re-
views have described detailed pathways by which the circadian
clock may directly mediate lipid and glucose metabolism, as
well as cardiovascular function [41,67,69,70]. Of particular
interest are CCGs that contain binding sites in their promoter
regions for core clock genes, which include albumin D-element
binding protein (Dbp), orphan nuclear receptors (NRs) (i.e.
Rev-erba and Rora), NRs (i.e. peroxisome proliferator-acti-
vated receptor a [PPARa]), and plasminogen activator inhibi-
tor type 1 (PAI-1).
The family of orphan NRs consisting of Rev-erba and Rora
have received signiﬁcant attention as a potential molecular link
between the circadian, metabolic, and cardiovascular systems.
Recent studies have shown reciprocal binding between the
CLOCK:BMAL1 transcription factor and Rev-erba and
Rora, that forms the basis of a circadian clock gene feedback
loop (described above)[3]. Nuclear receptors serve important
roles in lipid and carbohydrate metabolism, as well as in medi-
ating vascular inﬂammatory responses [59]. For example, Rev-
erba mRNA expression promotes adipocyte diﬀerentiation
and REV-ERBa is phosphorylated by glycogen synthase ki-
nase 3, an enzyme involved in carbohydrate metabolism [59].
Using mouse ﬁbroblast cells, it was shown that Bmal1 is a
mediating factor in adipocyte diﬀerentiation, as well as down-
stream eﬀects of PPARc [71]. RORa, which activates Bmal1
transcription, also mediates lipogenesis and lipid storage in
skeletal muscle [59]. Rev-erba has been implicated in the regu-
lation of cytokine-mediated inﬂammatory responses in vascu-
lar smooth muscle cells, as well as in the regulation of theexpression of PAI-1 [59]. Increased levels of PAI-1 inhibit tis-
sue plasminogen activator (tPA), resulting in reduced ﬁbrino-
lysis and an increased risk for thrombolytic events. Another
nuclear receptor, PPARa, is a lipid responsive protein involved
in lipid and glucose metabolism. In Clock mutant mice on a
mixed background, the circadian expression of Ppara mRNA
in the liver and of Pai-1 mRNA in the heart was signiﬁcantly
attenuated compared to control animals [72,73]. Another study
found that Clock mutant mice (mixed background) exhibited
impaired gluconeogenesis in response to an insulin tolerance
test and were resistant to the hyperglycemic eﬀects of a high
fat diet [74]. Taken together, these ﬁndings indicate that NRs
may represent an important molecular link between the circa-
dian clock and components of the metabolic syndrome, includ-
ing adiposity, hypertension, and hyperlipidemia.
Type II diabetes has also been associated with the metabolic
syndrome and a number of intriguing links between diabetes
and circadian rhythmicity have been identiﬁed. Core clock
genes, as well as Dbp and Rev-erb-a, are expressed in a circa-
dian manner in insulin-releasing cells of the pancreas [75].
Streptozotocin-induced diabetes in rats results in notable
phase advances in the rhythmic expression of circadian clock
genes and CCGs in the heart [76]. In a mouse model of diabe-
tes, mild STZ-induced beta cell damage resulted in exaggerated
circadian responses in locomotor activity in response to light
(i.e. phase shifts), whereas, subsequent treatment with insulin
in these same animals corrected the phase response to the light
pulse [58]. Oppositely, reduced glucose availability induced by
2-deoxy-D-glusose injections attenuated the phase shifting ef-
fects of light on activity in mice [57]. Finally, there are indica-
tions that Clock/Clock mutant and Bmal1/ deﬁcient mice
exhibit deﬁcits in insulin regulation and beta cell function
[74]. Thus, clock gene disruption in pancreatic beta cells could
underlie the loss of rhythmicity in insulin secretion and glucose
tolerance exhibited by patients with type II diabetes.3. Summary
This review has presented some of the accumulating evi-
dence indicating that chronic partial sleep loss, circadian
desynchronization, and/or alterations in clock gene function
can lead to signiﬁcant changes in energy homeostasis and car-
diovascular function. The discovery that circadian clock genes
are directly involved in molecular pathways of lipid and glu-
cose regulation, inﬂammatory responses, and sleep–wake reg-
ulation, has provided a new framework in which to examine
the role of the circadian clock system in multiple disease pro-
cesses. The ﬁelds of sleep research and circadian biology are
in a unique position to make major contributions to the under-
standing of behavioral, physiological, and molecular mecha-
nisms that are responsible for epidemic diseases, such as
obesity, diabetes, and metabolic syndrome.
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